Get the Scoop: Entera Bio and OPKO Health Share Exciting News on Oral Oxyntomodulin GLP-1 Glucagon Peptide Tablet Candidate for Obesity and Metabolic Disorders
Get the Scoop: Exciting News on Oral Oxyntomodulin GLP-1 Glucagon Peptide Tablet Candidate JERUSALEM and MIAMI, Sept. 25, 2024 (GLOBE NEWSWIRE) – Entera Bio Ltd. (NASDAQ: ENTX) and OPKO Health, Inc. (NASDAQ: OPK) Entera Bio Ltd. (Entera) and OPKO Health, Inc. (OPKO) have just revealed groundbreaking results from their joint research project, combining an innovative…